The Scottish Government Scottish Health and Industry Partnership (SHIP) wish to engage with interested suppliers in the marketplace prior to a future Small Business Research Initiative (SBRI) for Medicines and Dementia.
Preliminary Market Consultation (Innovation): SBRI Open Innovation Competition on Medicines and Dementia
The Scottish Government Scottish Health and Industry Partnership (SHIP) plan to launch a future Small Business Research Initiative (SBRI). At this stage further dialogue with possible industry partners is desirable. As part of this Preliminary Market Consultation process, we wish to engage with interested suppliers in the marketplace. For further details please access the following link and note your interest to access supporting documents and Question and Answer facilities:
Please submit any questions regarding the Preliminary Market Consultation through Public Contracts Scotland via the Question and Answer function accessible by the following:
Background The Scottish Government is launching a Small Business Research Initiative (SBRI) Open Innovation Competition via Innovate UK at the end of February 2023.
The Scottish Government Scottish Health and Industry Partnership (SHIP) are investing GBP 240,000 in support of this future challenge. The goal of innovation, service redesign and development of workforce initiatives is to deliver sustainable, accessible and equitable services which improve the quality of life of people at risk of dementia by identifying them earlier and slowing the time to full diagnosis.
This Open Innovation Challenge will provide an opportunity for companies, working in partnership with regional test beds to develop disruptive innovative solutions that focus on medicines and developing innovative new tools for use in clinical practice to support people at risk of developing dementia to manage their medications. The challenge is centred around mid-life management in people with risk-factors or early signs of dementia.
Innovation themes are:
Identification of people utilising clinical risk factors.
Adherence to medicines for conditions identified as being linked to the development of dementia
Please note that this notice is for Preliminary Market Consultation for pre-tender supplier engagement only. Further information will be available via Innovate UK when the competition launches, anticipated to take place on 27th February 2023. This will include a briefing pack, applicants’ guidance and an online event. Details regarding how to register for the event will be provided as part of the briefing pack available from Innovate UK. Please submit any questions regarding the Preliminary Market Consultation through Public Contracts Scotland via the Question and Answer function accessible by the following link:
Please note that this notice is for Preliminary Market Consultation for pre-tender supplier engagement only. A date for the Pre-Commercial Procurement Notice for a future competition is to be advised. Applications are welcome from any type of organisation of any size (registered in the UK, EU or EEA) that can demonstrate a credible and practical route to market. Successful Applicants for the Pre-Commercial Procurement will be able to work in partnership with a research partner site to serve as the 'test bed' to develop the innovation and to collect real-world evidence in support of future potential product approval and use across the NHS Scotland health system. When the Pre-Commercial Procurement becomes available, interested parties must make a separate application for the competition on Innovate UK.